Chen Xuan, Sun Meifang, Mao Xiuhong, Liu Xiaoxia, Sun Weihe
Department of Intensive Care Unit, Affiliated Dongtai Hospital of Nantong University, Dongtai, Jiangsu 224200, P.R. China.
Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Exp Ther Med. 2019 Apr;17(4):2720-2724. doi: 10.3892/etm.2019.7246. Epub 2019 Feb 6.
Continuous veno-venous hemofiltration (CVVH) in the treatment of severe acute pancreatitis (SAP) was investigated. A total of 60 patients with SAP treated in Affiliated Dongtai Hospital of Nantong University from October 2015 to October 2017 were enrolled in this retrospective study. Among them, 32 patients received CVVH and routine internal medicine therapy (the CVVH group), and 28 received routine internal medicine therapy (the control group). Then biochemical indexes and severity of SAP after treatment were detected to investigate the roles of CVVH and routine internal medicine therapy in treating SAP. Inflammatory factors in both the CVVH and control groups were significantly decreased after treatment (P<0.05), and CVVH could eliminate more factors. Comparison of blood biochemical indexes between the CVVH and control groups were carried out. Significant improvement was found (P<0.05) after CVVH and routine internal medicine therapy. Besides, Acute Physiology and Chronic Health Evaluation (APACHE)-II grade was significantly decreased in the CVVH group compared with that in the control group after 7 days. CVVH therapy can effectively reduce the levels of inflammatory factors in SAP patients, improve their biochemical and physiological indicators, and have high clinical application value.
研究了持续静脉-静脉血液滤过(CVVH)治疗重症急性胰腺炎(SAP)的效果。纳入了2015年10月至2017年10月在南通大学附属东台医院接受治疗的60例SAP患者进行这项回顾性研究。其中,32例患者接受CVVH联合常规内科治疗(CVVH组),28例接受常规内科治疗(对照组)。然后检测治疗后SAP的生化指标和严重程度,以探讨CVVH和常规内科治疗在治疗SAP中的作用。治疗后CVVH组和对照组的炎症因子均显著降低(P<0.05),且CVVH能清除更多因子。对CVVH组和对照组的血液生化指标进行比较。CVVH联合常规内科治疗后有显著改善(P<0.05)。此外,7天后CVVH组的急性生理与慢性健康状况评分系统(APACHE)-II分级与对照组相比显著降低。CVVH治疗可有效降低SAP患者炎症因子水平,改善其生化和生理指标,具有较高的临床应用价值。